HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1101	2723 CHUI HC, TIERNEY M, ZAROW C, LEWIS A, SOBEL E, et al. NEUROPATHOLOGIC DIAGNOSIS OF ALZHEIMER-DISEASE - INTERRATER RELIABILITY IN THE ASSESSMENT OF SENILE PLAQUES AND NEUROFIBRILLARY TANGLES ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1993 SPR; 7 (1): 48-54	5	19	1	25
1102	2900 KAZEE AM, ESKIN TA, LAPHAM LW, GABRIEL KR, MCDANIEL KD, et al. CLINICOPATHOLOGICAL CORRELATES IN ALZHEIMER-DISEASE - ASSESSMENT OF CLINICAL AND PATHOLOGICAL DIAGNOSTIC-CRITERIA ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1993 FAL; 7 (3): 152-164	17	68	2	24
1103	2994 WISNIEWSKI HM, CONSTANTINIDIS J, WEGIEL J, BOBINSKI M, TARNAWSKI M NEUROFIBRILLARY PATHOLOGY IN BRAINS OF ELDERLY SCHIZOPHRENICS TREATED WITH NEUROLEPTICS ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1994; 8 (4): 211-227	22	39	3	59
1104	3549 Matsushima H, Shimohama S, Fujimoto S, Takenawa T, Kimura J Reduction of platelet phospholipase C activity in patients with Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1995 WIN; 9 (4): 213-217	1	14	3	39
1105	3550 Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, et al. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: Evidence that the disorders are distinct ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1995 WIN; 9 (4): 218-222	7	11	11	27
1106	4179 Treves TA, Bornstein NM, Chapman J, Klimovitzki S, Verchovsky R, et al. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 WIN; 10 (4): 189-191	7	34	2	31
1107	4324 Armstrong RA, Wood L Spatial pattern analysis of beta-amyloid (A beta) deposits in Alzheimer disease by linear regression ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 SPR; 10 (1): 40-45	0	5	4	30
1108	5479 Peskind ER, Leverenz J, Farlow MR, Ito RK, Provow SA, et al. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997 DEC; 11 (4): 201-206	4	9	4	29
1109	5770 Warzok RW, Kessler C, Apel G, Schwarz A, Egensperger R, et al. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 MAR; 12 (1): 33-39	12	48	4	47
1110	6260 Mecocci P, Cherubini A, Bregnocchi M, Chionne F, Cecchetti R, et al. Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 SEP; 12 (3): 211-214	46	51	8	23
#	Date / Author / Journal	LCS	GCS	LCR	CR
1111	6532 Kurz A, Riemenschneider S, Buch K, Willoch F, Bartenstein P, et al. Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 DEC; 12 (4): 372-377	27	42	4	30
1112	6975 Kowall NW Alzheimer disease 1999: A status report ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 APR-JUN; 13: S11-S16	0	13	13	82
1113	6976 Fine RE The biochemistry of Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 APR-JUN; 13: S82-S87	0	5	13	49
1114	7660 Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV, et al. The cognitive syndrome of vascular dementia: Implications for clinical trials ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 DEC; 13: S21-S29	1	36	3	88
1115	7661 Pantoni L, Leys D, Fazekas F, Longstreth WT, Inzitari D, et al. Role of white matter lesions in cognitive impairment of vascular origin ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 DEC; 13: S49-S54	4	36	14	48
1116	7774 Frangione B, Vidal R, Rostagno A, Ghiso J Familial cerebral amyloid angiopathies and dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000; 14: S25-S30	0	7	5	46
1117	9134 Imamura K, Sawada M, Ozaki T, Naito H, Iwata T, et al. Activation mechanism of brain microglia in patients with diffuse neurofibrillary tangles with calcification: A comparison with Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2001 JAN-MAR; 15 (1): 45-50	4	4	4	28
1118	10201 Fillit HN, O'Connell AW, Brown WM, Altstiel LD, Anand R, et al. Barriers to drug discovery and development for Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S1-S8	2	7	6	46
1119	10202 Khachaturian ZS Models and modeling systems in Alzheimer disease drug discovery ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S9-S12	0	1	9	44
1120	10203 Ferris SH Clinical trials in AD: Are current formats and outcome measures adequate? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S13-S17	0	4	2	51
#	Date / Author / Journal	LCS	GCS	LCR	CR
1121	10204 Altstiel LD Barriers to Alzheimer disease drug discovery and development in the biotechnology industry ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S29-S32	0	1	3	28
1122	10205 Valle R, Lee B Research priorities in the evolving demographic landscape of Alzheimer disease and associated dementias ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S64-S76	1	7	2	140
1123	10951 Csernansky JG, Miller JP, McKeel D, Morris JC Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer type ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 JUL-SEP; 16 (3): 144-149	14	16	9	31
1124	10952 Xu GL, Gonzales V, Borchelt DR A beta deposition does not cause the aggregation of endogenous tau in transgenic mice ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 JUL-SEP; 16 (3): 196-201	4	7	21	44
1125	11257 Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida Brain Bank ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 OCT-DEC; 16 (4): 203-212	55	116	6	59
1126	11823 Black BS, Kasper J, Brandt J, Shore AD, German P, et al. Identifying dementia in high-risk community samples: The memory and medical care study ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JAN-MAR; 17 (1): 9-18	0	9	2	62
1127	12108 Krefft TA, Graff-Radford NR, Dickson DW, Baker M, Castellani RJ Familial primary progressive aphasia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 APR-JUN; 17 (2): 106-112	10	14	4	17
1128	12405 DeKosky S Early intervention is key to successful management of Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17: S99-S104	2	22	5	61
1129	12406 Swaab DF, Dubelaar EJG, Scherder EJA, van Someren EJW, Verwer RWH Therapeutic strategies for Alzheimer disease - Focus on neuronal reoctivotion of metobolicolly impoired neurons ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17: S114-S122	2	12	11	120
1130	12407 Bush AI Copper, zinc, and the metallobiology of Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17 (3): 147-150	6	35	5	40
#	Date / Author / Journal	LCS	GCS	LCR	CR
1131	12408 Atiya M, Hyman BT, Albert MS, Killiany R Structural magnetic resonance imaging in established and prodromal Alzheimer disease: A review ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17 (3): 177-195	4	26	10	153
1132	12735 Kertesz A, Davidson W, McCabe P, Munoz D Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 OCT-DEC; 17 (4): 223-229	26	43	3	37
1133	12736 Morris JC Dementia update 2003 ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 OCT-DEC; 17 (4): 245-258	5	14	35	170
1134	13289 Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2004 JAN-MAR; 18 (1): 17-21	7	72	3	45
1135	14363 Klunemann HH, Rogaeva E, Neumann M, Kretzschmar HA, Kandel M, et al. Novel PSI mutation in a Bavarian kindred with familial Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2004 OCT-DEC; 18 (4): 256-258	2	4	3	11
1136	14364 Galvin JE, Ginsberg SD Expression profiling and pharmacotherapeutic development in the central nervous system ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2004 OCT-DEC; 18 (4): 264-269	6	8	28	69
1137	14877 Chow TW, Hodges JR, Dawson KE, Miller BL, Smith V, et al. Referral patterns for syndromes associated with frontotemporal lobar degeneration ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 JAN-MAR; 19 (1): 17-19	1	1	4	7
1138	15248 Webber KM, Casadesus G, Perry G, Atwood CS, Bowen R, et al. Gender differences in Alzheimer disease - The role of luteinizing hormone in disease pathogenesis ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 APR-JUN; 19 (2): 95-99	3	13	9	58
1139	15249 Morris JC Dementia update 2005 ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 APR-JUN; 19 (2): 100-117	5	20	36	209
1140	15970 Knibb JA, Hodges JR Semantic dementia and primary progressive aphasia: A problem of categorization? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S7-S14	5	8	10	61
#	Date / Author / Journal	LCS	GCS	LCR	CR
1141	15971 Kertesz A Frontotemporal dementia: One disease, or many? Probably one, possibly two ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S19-S24	5	11	6	20
1142	15972 Kar A, Kuo D, He RQ, Zhou JW, Wu JY Tau alternative splicing and frontotemporal dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S29-S36	6	8	82	90
1143	15973 Katsuse O, Dickson DW Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S37-S43	25	28	12	30
1144	15974 Kimonis VE, Watts GDJ Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S44-S47	5	14	3	23
1145	15975 Chapman SB, Bonte FJ, Wong SBC, Zientz JN, Hynan LS, et al. Convergence of connected language and SPECT in variants of frontotemporal lobar degeneration ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19 (4): 202-213	3	7	12	64
1146	16596 Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, et al. The role of biomarkers in clinical trials for Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JAN-MAR; 20 (1): 6-15	39	70	22	95
1147	16597 Hardy J, Pittman A, Myers A, Fung HC, de Silva R, et al. Tangle diseases and the tau haplotypes ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JAN-MAR; 20 (1): 60-62	4	5	19	24
1148	16937 Stern Y Cognitive reserve and Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 APR-JUN; 20 (2): 112-117	5	59	1	73
1149	17324 Stern Y Cognitive reserve and Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JUL-SEP; 20 (3): S69-S74	5	55	1	73
1150	17707 Morris JC, Weintraub S, Chui HC, Cummings J, DeCarli C, et al. The uniform data set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer disease centers ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 OCT-DEC; 20 (4): 210-216	14	56	3	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
1151	17708 Galvin JE Cognitive change in Parkinson disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 OCT-DEC; 20 (4): 302-310	3	7	24	117
1152	17709 Lipinski B, Sajdel-Sulkowska EM New insight into Alzheimer disease: Demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 OCT-DEC; 20 (4): 323-326	0	4	3	28
1153	18344 Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, et al. Neuropathologic heterogeneity in HDDD1: A familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 JAN-MAR; 21 (1): 1-7	28	31	24	38
1154	18782 Bostrom F, Jonsson L, Minthon L, Londos E Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 APR-JUN; 21 (2): 150-154	8	9	2	26
1155	18783 Kertesz A, Blair M, McMonagle P, Munoz DG The diagnosis and course of frontotemporal dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 APR-JUN; 21 (2): 155-163	19	26	27	67
1156	19605 Brun A Identification and characterization of frontal lobe degeneration - Historical perspective on the development of FTD ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S3-S4	1	2	2	11
1157	19606 Kertesz A Pick complex - Historical introduction ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S5-S7	0	0	11	40
1158	19607 Mesulam MM Primary progressive aphasia - A 25-year retrospective ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S8-S11	3	8	17	37
1159	19608 Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): Current limitations and future directions ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S14-S18	16	24	29	85
1160	19609 Miller BL Frontotemporal dementia and semantic dementia - Anatomic variations on the some disease or distinctive entities? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S19-S22	4	5	15	32
#	Date / Author / Journal	LCS	GCS	LCR	CR
1161	19610 Ogar JM, Dronkers NF, Brambati SM, Miller BL, Gorno-Tempini ML Progressive nonfluent aphasia and its characteristic motor speech deficits ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S23-S30	10	15	26	49
1162	19611 Boeve BF Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S31-S38	7	7	31	62
1163	19612 Hu WT, Parisi JE, Knopman DS, Boeve BF, Dickson DW, et al. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S39-S43	4	4	16	25
1164	19613 Mackenzie IRA The neuropathology of FTD associated with ALS ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S44-S49	12	13	36	64
1165	19614 Knopman DS, Boeve BS, Caselli RJ, Graff-Radford NR, Kramer JH, et al. Longitudinal tracking of FTLD - Toward developing clinical trial methodology ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S58-S63	3	7	12	22
1166	19615 Boxer AL, Boeve BF Frontotemporal dementia treatment: Current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S79-S87	13	15	47	106
1167	19616 Shi QL, Gibson GE Oxidative stress and transcriptional regulation in Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): 276-291	9	41	31	225
1168	20276 Jarvik L, Larue A, Blacker D, Gatz M, Kawas C, et al. Children of persons with Alzheimer disease - What does the future hold? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JAN-MAR; 22 (1): 6-20	0	2	13	202
1169	20277 Kapaki E, Paraskevas GP, Papageorgiou SG, Bonakis A, Kalfakis N, et al. Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JAN-MAR; 22 (1): 47-53	15	16	30	45
1170	20278 Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, et al. Brain N-acetylaspartate is reduced in Parkinson disease with dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JAN-MAR; 22 (1): 54-60	4	6	13	46
#	Date / Author / Journal	LCS	GCS	LCR	CR
1171	20751 Bain LJ, Barker W, Loewenstein DA, Duara R Towards an earlier diagnosis of Alzheimer disease (Proceedings of the 5th MCI Symposium, 2007) ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 APR-JUN; 22 (2): 99-110	0	1	5	37
1172	20752 Larner AJ Mutation negative "Early-onset Familial Alzheimer Disease": Consider screening for tau gene mutations ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 APR-JUN; 22 (2): 194-195	1	4	3	3
1173	21234 Klunk WE, Mathis CA Whatever happened to Pittsburgh Compound-A? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JUL-SEP; 22 (3): 198-203	0	0	17	42
1174	21648 Geroldi C, Canu E, Bruni AC, Dal Forno G, Ferri R, et al. The Added Value of Neuropsychologic Tests and Structural Imaging for the Etiologic Diagnosis of Dementia in Italian Expert Centers ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 OCT-DEC; 22 (4): 309-320	2	3	7	25
1175	21649 Chow TW, Binns MA, Freedman M, Stuss DT, Ramirez J, et al. Overlap in Frontotemporal Atrophy Between Normal Aging and Patients With Frontotemporal Dementias ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 OCT-DEC; 22 (4): 327-335	0	1	10	37
1176	21650 Rogalski E, Rademaker A, Mesulam M, Weintraub S Covert Processing of Words and Pictures in Nonsemantic Variants of Primary Progressive Aphasia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 OCT-DEC; 22 (4): 343-351	1	3	11	43
1177	22342 Cosentino M, Colombo C, Mauri M, Ferrari M, Corbetta S, et al. Expression of Apoptosis-related Proteins and of mRNA for Dopaminergic Receptors in Peripheral Blood Mononuclear Cells From Patients With Alzheimer Disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 JAN-MAR; 23 (1): 88-90	1	2	3	17
1178	23256 Sabbagh MN, Sandhu SS, Farlow MR, Vedders L, Shill HA, et al. Correlation of Clinical Features With Argyrophilic Grains at Autopsy ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 JUL-SEP; 23 (3): 229-233	0	0	9	31
1179	23257 Prodan CI, Ross ED, Vincent AS, Dale GL Differences in Coated-platelet Production Between Frontotemporal Dementia and Alzheimer Disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 JUL-SEP; 23 (3): 234-237	0	2	9	27
1180	23770 Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, et al. Cognitive and Neuropsychiatric Profile of the Synucleinopathies Parkinson Disease, Dementia With Lewy Bodies, and Multiple System Atrophy ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 OCT-DEC; 23 (4): 365-370	2	4	15	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
1181	23771 Ito M, Echizenya N, Nemoto D, Kase M A Case Series of Epilepsy-derived Memory Impairment Resembling Alzheimer Disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 OCT-DEC; 23 (4): 406-409	0	3	1	22
1182	25090 Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, et al. Lewy Body Dementia Caregiver Burden and Unmet Needs ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 APR-JUN; 24 (2): 177-181	0	0	7	27
1183	25091 Rosenbloom MH, Finley R, Scheinman MM, Feldman MD, Miller BL, et al. Donepezil-associated Bradyarrhythmia in a Patient With Dementia With Lewy Bodies (DLB) ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 APR-JUN; 24 (2): 209-211	0	0	1	11
1184	25582 McEvoy LK, Edland SD, Holland D, Hagler DJ, Roddey JC, et al. Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer Disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 JUL-SEP; 24 (3): 269-277	1	1	10	53
1185	25583 Tolboom N, Koedam ELGE, Schott JM, Yaqub M, Blankenstein MA, et al. Dementia Mimicking Alzheimer's Disease Owing to a Tau Mutation: CSF and PET Findings ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 JUL-SEP; 24 (3): 303-307	0	0	12	16
1186	26133 Gong G, O'Bryant SE The Arsenic Exposure Hypothesis for Alzheimer Disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 311-316	0	1	16	130
1187	26134 Kang SJ, Cha KR, Seo SW, Kim EA, Cheong HK, et al. Survival in Frontotemporal Lobar Degeneration in a Korean Population ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 339-342	0	0	15	23
1188	26135 Culo S, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, et al. Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies A Randomized Controlled-trial ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 360-364	0	0	3	32
1189	26136 Ferrari R, Kapogiannis D, Huey ED, Grafman J, Hardy J, et al. Novel Missense Mutation in Charged Multivesicular Body Protein 2B in a Patient With Frontotemporal Dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 397-401	0	0	13	37
1190	8968 Lewis J, Baker M, Van Slegtenhorst M, Hutton M Molecular genetics and transgenic modeling of the tauopathies ALZHEIMER'S DISEASE. 2001; : 71-85	1	1	30	36
#	Date / Author / Journal	LCS	GCS	LCR	CR
1191	8969 D'Souza I, Schellenberg GD Regulation of four-repeat tau expression: Interactions between exon and intron splicing regulatory sequences ALZHEIMER'S DISEASE. 2001; : 87-95	0	0	21	27
1192	8970 Wang DS, Cochran E, Bennett D, Mufson E, Eckman C, et al. Amyloid, PHF-tau, ubiquitin and synaptic markers in the progression of Alzheimer's disease: Immunochemical analyses of frontal cortex from prospectively studied elderly humans ALZHEIMER'S DISEASE. 2001; : 165-180	4	8	9	30
1193	8971 Castillo GM, Kirschner DA, Yee AG, Snow AD Electron microscopy and X-ray diffraction studies further confirm the efficacy of PTI-00703 (R) (Cat's claw derivative) as a potential inhibitor of Alzheimer's beta-amyloid protein fibrillogenesis ALZHEIMER'S DISEASE. 2001; : 449-460	0	1	3	51
1194	8972 Grimm HS, Lichtenthaler SF, Beyreuther K, Hartmann T Intracellular and secreted A beta(42/40) ratios are differently influenced by APP mutations ALZHEIMER'S DISEASE. 2001; : 479-486	1	1	5	26
1195	8973 Hashimoto M, Rockenstein E, Takenouchi T, Mallory M, Masliah E Mechanisms of alpha-synuclein and NAC fibrillogenesis ALZHEIMER'S DISEASE. 2001; : 569-586	0	0	36	67
1196	8974 Delacourte A Neurofibrillary degeneration: Patterns of tau isoform expression ALZHEIMER'S DISEASE. 2001; : 587-599	0	0	16	23
1197	8975 Nacharaju P, Yen S, Deture M, Easson C, Hutton M, et al. Pathogenic implication of altered tau properties caused by FTDP-17 mutations ALZHEIMER'S DISEASE. 2001; : 621-629	0	0	16	23
1198	8976 Takashima A, Tanemura K Formation of neurofibrillary tangles in mouse brain ALZHEIMER'S DISEASE. 2001; : 643-649	0	0	7	10
1199	8977 Sommer B, Barbieri S, Hofele K, Wiederhold KH, Probst A, et al. Lewy-like pathology in mice transgenic for mutant (A53T) and wild-type human alpha-synuclein ALZHEIMER'S DISEASE. 2001; : 661-670	0	0	20	32
1200	8978 Janus C, Pearson J, Horne P, Renlund R, Parisien K, et al. Changes in cognitive characteristics of Tg(APP)CRND8 mice at early stages of immunization with beta-amyloid peptide ALZHEIMER'S DISEASE. 2001; : 697-704	0	0	3	14

Date / Author / Journal

LCS

GCS

LCR

1101

2723 CHUI HC, TIERNEY M, ZAROW C, LEWIS A, SOBEL E, et al.

NEUROPATHOLOGIC DIAGNOSIS OF ALZHEIMER-DISEASE - INTERRATER RELIABILITY IN THE ASSESSMENT OF SENILE PLAQUES AND NEUROFIBRILLARY TANGLES

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1993 SPR; 7 (1): 48-54

1102

2900 KAZEE AM, ESKIN TA, LAPHAM LW, GABRIEL KR, MCDANIEL KD, et al.

CLINICOPATHOLOGICAL CORRELATES IN ALZHEIMER-DISEASE - ASSESSMENT OF CLINICAL AND PATHOLOGICAL DIAGNOSTIC-CRITERIA

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1993 FAL; 7 (3): 152-164

1103

2994 WISNIEWSKI HM, CONSTANTINIDIS J, WEGIEL J, BOBINSKI M, TARNAWSKI M

NEUROFIBRILLARY PATHOLOGY IN BRAINS OF ELDERLY SCHIZOPHRENICS TREATED WITH NEUROLEPTICS

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1994; 8 (4): 211-227

1104

3549 Matsushima H, Shimohama S, Fujimoto S, Takenawa T, Kimura J

Reduction of platelet phospholipase C activity in patients with Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1995 WIN; 9 (4): 213-217

1105

3550 Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, et al.

Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: Evidence that the disorders are distinct

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1995 WIN; 9 (4): 218-222

1106

4179 Treves TA, Bornstein NM, Chapman J, Klimovitzki S, Verchovsky R, et al.

APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 WIN; 10 (4): 189-191

1107

4324 Armstrong RA, Wood L

Spatial pattern analysis of beta-amyloid (A beta) deposits in Alzheimer disease by linear regression

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 SPR; 10 (1): 40-45

1108

5479 Peskind ER, Leverenz J, Farlow MR, Ito RK, Provow SA, et al.

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997 DEC; 11 (4): 201-206

1109

5770 Warzok RW, Kessler C, Apel G, Schwarz A, Egensperger R, et al.

Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 MAR; 12 (1): 33-39

1110

6260 Mecocci P, Cherubini A, Bregnocchi M, Chionne F, Cecchetti R, et al.

Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 SEP; 12 (3): 211-214

Date / Author / Journal

LCS

GCS

LCR

1111

6532 Kurz A, Riemenschneider S, Buch K, Willoch F, Bartenstein P, et al.

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 DEC; 12 (4): 372-377

1112

6975 Kowall NW

Alzheimer disease 1999: A status report

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 APR-JUN; 13: S11-S16

1113

6976 Fine RE

The biochemistry of Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 APR-JUN; 13: S82-S87

1114

7660 Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV, et al.

The cognitive syndrome of vascular dementia: Implications for clinical trials

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 DEC; 13: S21-S29

1115

7661 Pantoni L, Leys D, Fazekas F, Longstreth WT, Inzitari D, et al.

Role of white matter lesions in cognitive impairment of vascular origin

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999 DEC; 13: S49-S54

1116

7774 Frangione B, Vidal R, Rostagno A, Ghiso J

Familial cerebral amyloid angiopathies and dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000; 14: S25-S30

1117

9134 Imamura K, Sawada M, Ozaki T, Naito H, Iwata T, et al.

Activation mechanism of brain microglia in patients with diffuse neurofibrillary tangles with calcification: A comparison with Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2001 JAN-MAR; 15 (1): 45-50

1118

10201 Fillit HN, O'Connell AW, Brown WM, Altstiel LD, Anand R, et al.

Barriers to drug discovery and development for Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S1-S8

1119

10202 Khachaturian ZS

Models and modeling systems in Alzheimer disease drug discovery

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S9-S12

1120

10203 Ferris SH

Clinical trials in AD: Are current formats and outcome measures adequate?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S13-S17

Date / Author / Journal

1121

Barriers to Alzheimer disease drug discovery and development in the biotechnology industry

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S29-S32

1122

10205 Valle R, Lee B

Research priorities in the evolving demographic landscape of Alzheimer disease and associated dementias

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S64-S76

140

1123

10951 Csernansky JG, Miller JP, McKeel D, Morris JC

Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer type

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 JUL-SEP; 16 (3): 144-149

1124

10952 Xu GL, Gonzales V, Borchelt DR

A beta deposition does not cause the aggregation of endogenous tau in transgenic mice

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 JUL-SEP; 16 (3): 196-201

1125

11257 Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, et al.

Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida Brain Bank

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 OCT-DEC; 16 (4): 203-212

116

1126

11823 Black BS, Kasper J, Brandt J, Shore AD, German P, et al.

Identifying dementia in high-risk community samples: The memory and medical care study

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JAN-MAR; 17 (1): 9-18

1127

12108 Krefft TA, Graff-Radford NR, Dickson DW, Baker M, Castellani RJ

Familial primary progressive aphasia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 APR-JUN; 17 (2): 106-112

1128

12405 DeKosky S

Early intervention is key to successful management of Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17: S99-S104

1129

12406 Swaab DF, Dubelaar EJG, Scherder EJA, van Someren EJW, Verwer RWH

Therapeutic strategies for Alzheimer disease - Focus on neuronal reoctivotion of metobolicolly impoired neurons

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17: S114-S122

120

1130

12407 Bush AI

Copper, zinc, and the metallobiology of Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17 (3): 147-150

Date / Author / Journal

LCS

GCS

LCR

1131

12408 Atiya M, Hyman BT, Albert MS, Killiany R

Structural magnetic resonance imaging in established and prodromal Alzheimer disease: A review

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17 (3): 177-195

153

1132

12735 Kertesz A, Davidson W, McCabe P, Munoz D

Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 OCT-DEC; 17 (4): 223-229

1133

12736 Morris JC

Dementia update 2003

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 OCT-DEC; 17 (4): 245-258

170

1134

13289 Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL

Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2004 JAN-MAR; 18 (1): 17-21

1135

14363 Klunemann HH, Rogaeva E, Neumann M, Kretzschmar HA, Kandel M, et al.

Novel PSI mutation in a Bavarian kindred with familial Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2004 OCT-DEC; 18 (4): 256-258

1136

14364 Galvin JE, Ginsberg SD

Expression profiling and pharmacotherapeutic development in the central nervous system

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2004 OCT-DEC; 18 (4): 264-269

1137

14877 Chow TW, Hodges JR, Dawson KE, Miller BL, Smith V, et al.

Referral patterns for syndromes associated with frontotemporal lobar degeneration

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 JAN-MAR; 19 (1): 17-19

1138

15248 Webber KM, Casadesus G, Perry G, Atwood CS, Bowen R, et al.

Gender differences in Alzheimer disease - The role of luteinizing hormone in disease pathogenesis

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 APR-JUN; 19 (2): 95-99

1139

15249 Morris JC

Dementia update 2005

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 APR-JUN; 19 (2): 100-117

209

1140

15970 Knibb JA, Hodges JR

Semantic dementia and primary progressive aphasia: A problem of categorization?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S7-S14

Date / Author / Journal

1141

Frontotemporal dementia: One disease, or many? Probably one, possibly two

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S19-S24

1142

15972 Kar A, Kuo D, He RQ, Zhou JW, Wu JY

Tau alternative splicing and frontotemporal dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S29-S36

1143

15973 Katsuse O, Dickson DW

Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S37-S43

1144

15974 Kimonis VE, Watts GDJ

Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S44-S47

1145

15975 Chapman SB, Bonte FJ, Wong SBC, Zientz JN, Hynan LS, et al.

Convergence of connected language and SPECT in variants of frontotemporal lobar degeneration

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19 (4): 202-213

1146

16596 Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, et al.

The role of biomarkers in clinical trials for Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JAN-MAR; 20 (1): 6-15

1147

16597 Hardy J, Pittman A, Myers A, Fung HC, de Silva R, et al.

Tangle diseases and the tau haplotypes

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JAN-MAR; 20 (1): 60-62

1148

16937 Stern Y

Cognitive reserve and Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 APR-JUN; 20 (2): 112-117

1149

17324 Stern Y

Cognitive reserve and Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JUL-SEP; 20 (3): S69-S74

1150

17707 Morris JC, Weintraub S, Chui HC, Cummings J, DeCarli C, et al.

The uniform data set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer disease centers

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 OCT-DEC; 20 (4): 210-216

Date / Author / Journal

1151

Cognitive change in Parkinson disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 OCT-DEC; 20 (4): 302-310

117

1152

17709 Lipinski B, Sajdel-Sulkowska EM

New insight into Alzheimer disease: Demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 OCT-DEC; 20 (4): 323-326

1153

18344 Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, et al.

Neuropathologic heterogeneity in HDDD1: A familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 JAN-MAR; 21 (1): 1-7

1154

18782 Bostrom F, Jonsson L, Minthon L, Londos E

Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 APR-JUN; 21 (2): 150-154

1155

18783 Kertesz A, Blair M, McMonagle P, Munoz DG

The diagnosis and course of frontotemporal dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 APR-JUN; 21 (2): 155-163

1156

19605 Brun A

Identification and characterization of frontal lobe degeneration - Historical perspective on the development of FTD

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S3-S4

1157

19606 Kertesz A

Pick complex - Historical introduction

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S5-S7

1158

19607 Mesulam MM

Primary progressive aphasia - A 25-year retrospective

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S8-S11

1159

19608 Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, et al.

Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): Current limitations and future directions

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S14-S18

1160

19609 Miller BL

Frontotemporal dementia and semantic dementia - Anatomic variations on the some disease or distinctive entities?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S19-S22

Date / Author / Journal

LCS

GCS

LCR

1161

19610 Ogar JM, Dronkers NF, Brambati SM, Miller BL, Gorno-Tempini ML

Progressive nonfluent aphasia and its characteristic motor speech deficits

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S23-S30

1162

19611 Boeve BF

Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S31-S38

1163

19612 Hu WT, Parisi JE, Knopman DS, Boeve BF, Dickson DW, et al.

Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S39-S43

1164

19613 Mackenzie IRA

The neuropathology of FTD associated with ALS

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S44-S49

1165

19614 Knopman DS, Boeve BS, Caselli RJ, Graff-Radford NR, Kramer JH, et al.

Longitudinal tracking of FTLD - Toward developing clinical trial methodology

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S58-S63

1166

19615 Boxer AL, Boeve BF

Frontotemporal dementia treatment: Current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S79-S87

106

1167

19616 Shi QL, Gibson GE

Oxidative stress and transcriptional regulation in Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): 276-291

225

1168

20276 Jarvik L, Larue A, Blacker D, Gatz M, Kawas C, et al.

Children of persons with Alzheimer disease - What does the future hold?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JAN-MAR; 22 (1): 6-20

202

1169

20277 Kapaki E, Paraskevas GP, Papageorgiou SG, Bonakis A, Kalfakis N, et al.

Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JAN-MAR; 22 (1): 47-53

1170

20278 Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, et al.

Brain N-acetylaspartate is reduced in Parkinson disease with dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JAN-MAR; 22 (1): 54-60

Date / Author / Journal

LCS

GCS

LCR

1171

20751 Bain LJ, Barker W, Loewenstein DA, Duara R

Towards an earlier diagnosis of Alzheimer disease (Proceedings of the 5th MCI Symposium, 2007)

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 APR-JUN; 22 (2): 99-110

1172

20752 Larner AJ

Mutation negative "Early-onset Familial Alzheimer Disease": Consider screening for tau gene mutations

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 APR-JUN; 22 (2): 194-195

1173

21234 Klunk WE, Mathis CA

Whatever happened to Pittsburgh Compound-A?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JUL-SEP; 22 (3): 198-203

1174

21648 Geroldi C, Canu E, Bruni AC, Dal Forno G, Ferri R, et al.

The Added Value of Neuropsychologic Tests and Structural Imaging for the Etiologic Diagnosis of Dementia in Italian Expert Centers

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 OCT-DEC; 22 (4): 309-320

1175

21649 Chow TW, Binns MA, Freedman M, Stuss DT, Ramirez J, et al.

Overlap in Frontotemporal Atrophy Between Normal Aging and Patients With Frontotemporal Dementias

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 OCT-DEC; 22 (4): 327-335

1176

21650 Rogalski E, Rademaker A, Mesulam M, Weintraub S

Covert Processing of Words and Pictures in Nonsemantic Variants of Primary Progressive Aphasia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 OCT-DEC; 22 (4): 343-351

1177

22342 Cosentino M, Colombo C, Mauri M, Ferrari M, Corbetta S, et al.

Expression of Apoptosis-related Proteins and of mRNA for Dopaminergic Receptors in Peripheral Blood Mononuclear Cells From Patients With Alzheimer Disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 JAN-MAR; 23 (1): 88-90

1178

23256 Sabbagh MN, Sandhu SS, Farlow MR, Vedders L, Shill HA, et al.

Correlation of Clinical Features With Argyrophilic Grains at Autopsy

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 JUL-SEP; 23 (3): 229-233

1179

23257 Prodan CI, Ross ED, Vincent AS, Dale GL

Differences in Coated-platelet Production Between Frontotemporal Dementia and Alzheimer Disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 JUL-SEP; 23 (3): 234-237

1180

23770 Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, et al.

Cognitive and Neuropsychiatric Profile of the Synucleinopathies Parkinson Disease, Dementia With Lewy Bodies, and Multiple System Atrophy

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 OCT-DEC; 23 (4): 365-370

Date / Author / Journal

LCS

GCS

LCR

1181

23771 Ito M, Echizenya N, Nemoto D, Kase M

A Case Series of Epilepsy-derived Memory Impairment Resembling Alzheimer Disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2009 OCT-DEC; 23 (4): 406-409

1182

25090 Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, et al.

Lewy Body Dementia Caregiver Burden and Unmet Needs

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 APR-JUN; 24 (2): 177-181

1183

25091 Rosenbloom MH, Finley R, Scheinman MM, Feldman MD, Miller BL, et al.

Donepezil-associated Bradyarrhythmia in a Patient With Dementia With Lewy Bodies (DLB)

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 APR-JUN; 24 (2): 209-211

1184

25582 McEvoy LK, Edland SD, Holland D, Hagler DJ, Roddey JC, et al.

Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer Disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 JUL-SEP; 24 (3): 269-277

1185

25583 Tolboom N, Koedam ELGE, Schott JM, Yaqub M, Blankenstein MA, et al.

Dementia Mimicking Alzheimer's Disease Owing to a Tau Mutation: CSF and PET Findings

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 JUL-SEP; 24 (3): 303-307

1186

26133 Gong G, O'Bryant SE

The Arsenic Exposure Hypothesis for Alzheimer Disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 311-316

130

1187

26134 Kang SJ, Cha KR, Seo SW, Kim EA, Cheong HK, et al.

Survival in Frontotemporal Lobar Degeneration in a Korean Population

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 339-342

1188

26135 Culo S, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, et al.

Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies A Randomized Controlled-trial

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 360-364

1189

26136 Ferrari R, Kapogiannis D, Huey ED, Grafman J, Hardy J, et al.

Novel Missense Mutation in Charged Multivesicular Body Protein 2B in a Patient With Frontotemporal Dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 OCT-DEC; 24 (4): 397-401

1190

8968 Lewis J, Baker M, Van Slegtenhorst M, Hutton M

Molecular genetics and transgenic modeling of the tauopathies

ALZHEIMER'S DISEASE. 2001; : 71-85

Date / Author / Journal

LCS

GCS

LCR

1191

8969 D'Souza I, Schellenberg GD

Regulation of four-repeat tau expression: Interactions between exon and intron splicing regulatory sequences

ALZHEIMER'S DISEASE. 2001; : 87-95

1192

8970 Wang DS, Cochran E, Bennett D, Mufson E, Eckman C, et al.

Amyloid, PHF-tau, ubiquitin and synaptic markers in the progression of Alzheimer's disease: Immunochemical analyses of frontal cortex from prospectively studied elderly humans

ALZHEIMER'S DISEASE. 2001; : 165-180

1193

8971 Castillo GM, Kirschner DA, Yee AG, Snow AD

Electron microscopy and X-ray diffraction studies further confirm the efficacy of PTI-00703 (R) (Cat's claw derivative) as a potential inhibitor of Alzheimer's beta-amyloid protein fibrillogenesis

ALZHEIMER'S DISEASE. 2001; : 449-460

1194

8972 Grimm HS, Lichtenthaler SF, Beyreuther K, Hartmann T

Intracellular and secreted A beta(42/40) ratios are differently influenced by APP mutations

ALZHEIMER'S DISEASE. 2001; : 479-486

1195

8973 Hashimoto M, Rockenstein E, Takenouchi T, Mallory M, Masliah E

Mechanisms of alpha-synuclein and NAC fibrillogenesis

ALZHEIMER'S DISEASE. 2001; : 569-586

1196

8974 Delacourte A

Neurofibrillary degeneration: Patterns of tau isoform expression

ALZHEIMER'S DISEASE. 2001; : 587-599

1197

8975 Nacharaju P, Yen S, Deture M, Easson C, Hutton M, et al.

Pathogenic implication of altered tau properties caused by FTDP-17 mutations

ALZHEIMER'S DISEASE. 2001; : 621-629

1198

8976 Takashima A, Tanemura K

Formation of neurofibrillary tangles in mouse brain

ALZHEIMER'S DISEASE. 2001; : 643-649

1199

8977 Sommer B, Barbieri S, Hofele K, Wiederhold KH, Probst A, et al.

Lewy-like pathology in mice transgenic for mutant (A53T) and wild-type human alpha-synuclein

ALZHEIMER'S DISEASE. 2001; : 661-670

1200

8978 Janus C, Pearson J, Horne P, Renlund R, Parisien K, et al.

Changes in cognitive characteristics of Tg(APP)CRND8 mice at early stages of immunization with beta-amyloid peptide

ALZHEIMER'S DISEASE. 2001; : 697-704

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records